JPRN-jRCT2080222696未知3 期
A phase III long-term study of HP-3000 in patients with Parkinson's disease
适应症
试验速览
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
- 年龄范围
- >= 20age old 至 <= 79age old（—）
- 性别
- All
入选标准
- •Patients diagnosed with Parkinson's disease in stages 1 to 4 on the modified Hoehn & Yahr scale.
排除标准
- •- Patients with history of hypersensitivity to ropinirole.
- •- Patients with severe hepatic dysfunction.
- •- Patients who have cutaneous abnormality at planned application site that can be worsen by application with investigational product.
研究者
相似试验
未知
2 期
Phase II clinical study in patients with Parkinson's disease.Parkinson's diseaseJPRN-jRCT2080221631Hisamitsu Pharmaceutical Co., Inc.
未知
2 期
Phase 2/3 clinical study of HP-3150 in patients with cancer pain.Cancer painJPRN-jRCT2080222905Hisamitsu Pharmaceutical Co., Inc
未知
2 期
Phase II clinical study of HP-3150 in patients with low back pain.ow back painJPRN-jRCT2080222960Hisamitsu Pharmaceutical Co., Inc
未知
3 期
A phase III clinical study of HFT-290.Cancer painJPRN-jRCT2080223308Hisamitsu Pharmaceutical Co.,Inc.
未知
2 期
Phase II clinical study in patients with idiopathic restless legs syndrome.Idiopathic restless legs syndromeJPRN-jRCT2080222232Hisamitsu Pharmaceutical Co., Inc.